FDA approves Arkray’s new glucose monitoring system
EDINA, Minn. A manufacturer of diabetes self-monitoring systems announced that it received clearance from the Food and Drug Administration for its new Glucocard Vital blood glucose monitoring system.
Arkray said its new meter and strip platform, which will be available for distribution in early December, is expected to be a significant complement to the existing Glucocard line of products, and will be ideal for the home medical equipment, durable medical equipment, mail-order and managed care markets.
“We’re very excited about the latest addition to our Glucocard brand,” said Jonathan Chapman, president of Arkray USA. “The Vital meets all of Arkray’s rigorous design and performance standards. And we can offer it at a price point that will make it an ideal solution for our customers to use in competitive bidding.”
The new Glucocard Vital meter and strip platform is highly accurate, auto-coded, requires only 0.5 microliter of blood, holds 250 dowloadable tests in its memory and has a glucose oxydase strip chemistry that is not affected by interferences that cause testing errors in other common test strips.
The Vital, along with all Glucocard brands, is backed by Arkray’s unique YouChoose wellness program, a comprehensive education and support system that includes printed tools, videos, recipes and an integrated Web site designed to help patients manage their diabetes.
PDS Health launches diabetes, heart disease monitoring and management service
JUPITER, Fa. PDS Health on Monday announced the launch of wireless hardware diagnostics that work seamlessly with MDMonitor.com online software to monitor diabetes and heart disease.
“The name of the new wireless device is Celemonitor and it can submit the readings from patients’ glucose meters, blood pressure monitors and scales from anywhere,” the company stated.
The readings and data pertaining to the patient’s health is collected to MDMonitor.com and a designated caregiver can access the data.
Bayer Consumer Care introduces Citracal with heart-health formula
MORRISTOWN, N.J. Bayer Consumer Care on Wednesday announced the introduction of Citracal calcium plus heart health as one of the first calcium supplements that helps support both bone and heart health.
The new formulation contains 1,260-mg of calcium per daily dose, more than any other leading brand, and has advanced levels of vitamin D to support calcium absorption. It also contains phytosterols, a natural plant ingredient that may reduce the risk of heart disease by lowering cholesterol, the company stated.
“Calcium and vitamin D are critical for bone health, yet most women aren’t always getting enough of these important nutrients,” stated Julie Upton, Bayer spokeswoman. “I’m excited that women now have a new option that helps ensure they get enough calcium and vitamin D, as well as natural plant sterols, which may help to reduce their risk of heart disease, the No. 1 killer of women.”
“We strive to continue to develop new and innovative products to meet our consumers’ changing concerns,” stated Angela Vann, senior brand manager – Citracal. “Women need to attend to bone and heart health daily, and this product conveniently allows them to address both of these important health issues at the same time.”